Compare ARK Genomic Revolution ETF (ARKG) vs OneSpan Inc (OSPN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs OneSpan Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while OneSpan Inc trades at $15.17 (market cap $561.84M). The key difference: OneSpan Inc pays a 3.43% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | OSPN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $16.32 |
52-Week Low | $23.09 | $10.15 |
Market Cap | — | $561.84M |
Enterprise Value | — | $520.04M |
Dividend Yield | — | 3.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
OneSpan (OSPN) trades at $15.17, down slightly by 0.26% today, with a bullish technical outlook supported by moving averages. The stock shows strong profitability with a 28.47% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights investor attention and the upcoming Q2 2026 earnings release on August 4, 2026, alongside strategic leadership appointments to accelerate growth.
The outlook remains positive given consistent earnings beats and high analyst buy ratings, though risks include negative cash flow trends and competitive pressures. Upside potential exists if the company maintains its earnings momentum, but investors should monitor cash flow improvements and execution of growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
